Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 1

Research Article

Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed Rats

Table 1

Summary of metabolic parameters in chow and HFD fed rats with variety of treatments.

ChowHFD-Con.HFD-RSGHFD-SGE

Initial body weight, g372 ± 16414 ± 14409 ± 20417 ± 16
Final body weight, g412 ± 22468 ± 19483 ± 32438 ± 27*
Visceral fat mass, g7.8 ± 1.214.60 ± 1.2017.0 ± 1.48.9 ± 1.0**
Liver wt, g11.7 ± 0.212.50 ± 0.9013.3 ± 0.611.8 ± 0.6
Serum glucose, mM6.75 ± 0.148.87 ± 0.247.65 ± 0.14*8.15 ± 0.18
Serum insulin, mU26.60 ± 0.2246.25 ± 0.3524.01 ± 0.18**27.03 ± 0.31**
HOMA-IR7.98 ± 0.0918.23 ± 0.288.16 ± 0.17**9.76 ± 0.29**
Serum TC, mM3.98 ± 0.215.67 ± 0.245.13 ± 0.324.35 ± 0.18*
Serum TG, mM0.41 ± 0.031.03 ± 0.060.59 ± 0.03*0.51 ± 0.02**
Serum HDL-C, mM1.20 ± 0. 220.86 ± 0.130.90 ± 0.160.96 ± 0.15
Serum LDL-C, mM2.59 ± 0.524.34 ± 0.593.96 ± 0.673.16 ± 0.56*
Serum NEFA, mM0.50 ± 0.100.77 ± 0.210.57 ± 0.12*0.58 ± 0.12*

Data are means ± SEM;  rats/group. , versus chow control; * and ** compared with HFD-Con. HOMA is defined as (fasting insulin × fasting glucose)/22.5. Visceral fat included epididymal fat pad and inguinal fat. TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; NFFA: nonfree fatty acids.